Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Estradiol

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0311-2026
Class II · Moderate risk

Estradiol

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0310-2026
Class II · Moderate risk

Estradiol

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0309-2026
Class II · Moderate risk

Estradiol

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0308-2026
Class II · Moderate risk

Estradiol

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0307-2026
Class III · Low risk

Doxazosin Tablets

Tablets/Capsules Imprinted with Wrong ID

Ongoing Labeling / mix-up Unichem Pharmaceuticals USA Inc. NDC 29300-353-10 D-0306-2026
Class II · Moderate risk

Dynarex

CGMP Deviations

Ongoing cGMP deviation Acme United Corporation NDC 67777-245-04 D-0376-2026
Class II · Moderate risk

Dynarex

CGMP Deviations

Ongoing cGMP deviation Acme United Corporation NDC 67777-245-01 D-0375-2026
Class II · Moderate risk

Wipes Plus

CGMP Deviations

Ongoing cGMP deviation Acme United Corporation NDC 67151-333-01 D-0368-2026

Recalls by year